Technical Analysis for GSGTF - Gensight Biologics Sa

Grade Last Price % Change Price Change
grade C 1.8 -7.69% -0.1500
GSGTF closed down 7.69 percent on Monday, June 10, 2019, on 5 percent of normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical GSGTF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -7.69%
Gapped Down Weakness -7.69%
Narrow Range Bar Range Contraction -14.69%
Gapped Up Strength -14.69%
Narrow Range Bar Range Contraction -14.29%

Older signals for GSGTF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye, and central nervous system. The company develops its products through gene therapy-based approach with technology platforms of mitochondrial targeting sequence and optogenetics. Its lead product candidates include GS010, an AAV2 containing the human wild-type ND4 gene, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy associated with mutation in the ND4 gene; and GS030 that comprises a gene encoding photoactivatable channelrhodopsin for the treatment of reinitis pigmentosa and geographic atrophy in dry age-related macular degeneration. The company also develops products that are preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was founded in 2012 and is headquartered in Paris, France.
Biotechnology RTT Biopharmaceutical Life Sciences Biology Technology Platforms Gene Therapy Macular Degeneration Its Products Senescence Its
Is GSGTF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 3.6
52 Week Low 1.8
Average Volume 6,171
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.8000
Resistance 3 (R3) 1.8000 1.8000 1.8000
Resistance 2 (R2) 1.8000 1.8000 1.8000 1.8000
Resistance 1 (R1) 1.8000 1.8000 1.8000 1.8000 1.8000
Pivot Point 1.8000 1.8000 1.8000 1.8000 1.8000
Support 1 (S1) 1.8000 1.8000 1.8000 1.8000 1.8000
Support 2 (S2) 1.8000 1.8000 1.8000 1.8000
Support 3 (S3) 1.8000 1.8000 1.8000
Support 4 (S4) 1.8000